Renal Cancer - Results from #5880

Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence. January 19, 2016

Retrospective analysis of survival after resection of pancreatic renal cell carcinoma metastases January 19, 2016

Effects of stimulating interleukin -2/anti- interleukin -2 antibody complexes on renal cell carcinoma January 19, 2016

Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis January 18, 2016

Comparative Effectiveness of Everolimus and Axitinib as Second Targeted Therapies for Metastatic Renal Cell Carcinoma in the US: A Retrospective Chart Review January 18, 2016

ALK-Rearranged Renal Cell Carcinomas in Children January 18, 2016

High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma January 15, 2016

Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study January 14, 2016

Check Point Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection January 14, 2016

Tyrosine kinase inhibitors target cancer stem cells in renal cell cancer January 4, 2016

MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis January 4, 2016

Real-World Effectiveness of Everolimus Subsequent to Different First Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Synthesis of Retrospective Chart Reviews January 4, 2016

Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus January 4, 2016

Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy January 4, 2016

Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status January 1, 2016

Renal cavernous hemangioma: robot-assisted partial nephrectomy with selective warm ischemia. Case report and review of the literature December 31, 2015

Active Surveillance for Small Renal Masses: A Review of the Aims and Preliminary Results of the DISSRM Registry December 31, 2015

Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors December 31, 2015

Efficacy of fourth-line targeted therapy in patients with metastatic renal cell carcinoma: a retrospective analysis December 29, 2015

Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma December 28, 2015

Page 295 of 456